Receptor News and Research

RSS
New molecule promotes gut healing and suppresses tumor growth in colorectal cancer

New molecule promotes gut healing and suppresses tumor growth in colorectal cancer

EZH2 enzyme drives aggressive tumor growth in treatment-resistant prostate cancer

EZH2 enzyme drives aggressive tumor growth in treatment-resistant prostate cancer

Fine particulate matter linked to higher eczema risk

Fine particulate matter linked to higher eczema risk

More than half of all US adults are eligible for semaglutide therapy

More than half of all US adults are eligible for semaglutide therapy

SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

Study provides insight into how low-dose ketamine alleviates symptoms of major depression

Study provides insight into how low-dose ketamine alleviates symptoms of major depression

New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer

New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer

Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss

Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss

Small Solutions for Big Problems in Drug Discovery and Delivery

Small Solutions for Big Problems in Drug Discovery and Delivery

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

How alcohol impacts male health

How alcohol impacts male health

How vitamin B3 could be the secret to living longer and protecting your heart

How vitamin B3 could be the secret to living longer and protecting your heart

Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients

Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients

Hypertension drug may reduce heart failure risk in people recovering from heart attack

Hypertension drug may reduce heart failure risk in people recovering from heart attack

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder

Active feedback improves pharmacist participation in heart failure treatment

Active feedback improves pharmacist participation in heart failure treatment

New oral painkiller developed for chronic abdominal pain

New oral painkiller developed for chronic abdominal pain

Spermidine regulates RIPK1 to combat diabetes and vascular damage

Spermidine regulates RIPK1 to combat diabetes and vascular damage

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.